World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
62
Citations
18070
World Ranking
2834
National Ranking
251

Richard Gilson publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Richard Gilson sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 265 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 234 scientists 205–214 publications: 208 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 224 publications — 58th percentile

58% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Richard Gilson D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Richard Gilson sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 112 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 123 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 94 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 62 D-Index — 49th percentile

49% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

Richard Gilson is affiliated with University College London in the United Kingdom. Their research primarily spans the field of medicine, with a focus on infectious diseases, epidemiology, emergency medicine, hepatology, and modeling and simulation. Within these areas, they have made contributions to several key topics including SARS-CoV-2 and COVID-19 research, HIV/AIDS research and interventions, HIV-related health complications and treatments, COVID-19 clinical research studies, liver disease diagnosis and treatment, COVID-19 epidemiological studies, and studies concerning HIV, drug use, and sexual risk.

Their publication record includes significant work in multiple respected journals and venues. Frequent publication outlets for their work include:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • HIV Medicine
  • Sexually Transmitted Infections
  • The Lancet
  • The Lancet HIV

Some of Richard Gilson's recent papers include:

  • "Pandemic peak SARS-CoV-2 infection and seroconversion rates in London frontline health-care workers," 2020, The Lancet
  • "2019 IUSTI-Europe guideline for the management of anogenital warts," 2020, Journal of the European Academy of Dermatology and Venereology
  • "A systematic review and meta-analysis of cytology and HPV-related biomarkers for anal cancer screening among different risk groups," 2022, International Journal of Cancer
  • "Long-term safety and efficacy of emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV-1 pre-exposure prophylaxis: week 96 results from a randomised, double-blind, placebo-controlled, phase 3 trial," 2021, The Lancet HIV
  • "Risk factors, symptom reporting, healthcare-seeking behaviour and adherence to public health guidance: protocol for Virus Watch, a prospective community cohort study," 2021, BMJ Open

Richard Gilson frequently collaborates with several coauthors, reflecting interdisciplinary and collaborative work across their research topics. Key coauthors include:

  • Margaret Johnson
  • Alison Rodger
  • Eleni Nastouli
  • Moira Spyer
  • Andrew Hayward

The diversity of their research topics and publication venues indicates a focus on both clinical and epidemiological dimensions of infectious diseases, with a notable emphasis on HIV/AIDS and COVID-19 related studies. The integration of modeling and simulation alongside clinical investigation also suggests involvement in a comprehensive approach to studying disease transmission and intervention strategies.

Best Publications

  • Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial.

    Sheena McCormack;David T. Dunn;Monica Desai;David I. Dolling

  • Sexual Activity Without Condoms and Risk of HIV Transmission in Serodifferent Couples When the HIV-Positive Partner Is Using Suppressive Antiretroviral Therapy

    Alison J. Rodger;Valentina Cambiano;Tina Bruun;Pietro Vernazza

  • The role of virus-specific CD8(+) cells in liver damage and viral control during persistent hepatitis B virus infection.

    Mala K. Maini;Carolina Boni;Chun Kyon Lee;Juan R. Larrubia

  • Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study

    Alison J Rodger;Valentina Cambiano;Tina Bruun;Pietro Vernazza

  • Impact on life expectancy of HIV-1 positive individuals of CD4+ cell count and viral load response to antiretroviral therapy

    Margaret T. May;Mark Gompels;Valerie Delpech;Kholoud Porter

  • Impact of late diagnosis and treatment on life expectancy in people with HIV-1: UK Collaborative HIV Cohort (UK CHIC) Study

    Margaret T May;Mark Gompels;Valerie Delpech;Kholoud Porter

  • Mortality in well controlled HIV in the continuous antiretroviral therapy arms of the SMART and ESPRIT trials compared with the general population.

    Alison J. Rodger;Rebecca Lodwick;Mauro Schechter;Steven Deeks

  • Temporal analysis of early immune responses in patients with acute hepatitis B virus infection.

    Claire Dunn;Dimitra Peppa;Pooja Khanna;Gaia Nebbia

  • Interactions between HIV and hepatitis B virus in homosexual men: effects on the natural history of infection.

    Richard J. C. Gilson;Anna E. Hawkins;Michael R. Beecham;Emma Ross

  • Recreational drug use, polydrug use, and sexual behaviour in HIV-diagnosed men who have sex with men in the UK: results from the cross-sectional ASTRA study

    Marina Daskalopoulou;Alison Rodger;Andrew N Phillips;Lorraine Sherr

  • Upregulation of the Tim-3/galectin-9 pathway of T cell exhaustion in chronic hepatitis B virus infection.

    Gaia Nebbia;Dimitra Peppa;Anna Schurich;Pooja Khanna

  • Blockade of Immunosuppressive Cytokines Restores NK Cell Antiviral Function in Chronic Hepatitis B Virus Infection

    Dimitra Peppa;Lorenzo Micco;Alia Javaid;Patrick T. F. Kennedy

  • Sexualized drug use (‘chemsex’) and high‐risk sexual behaviours in HIV‐positive men who have sex with men

    Unknown

  • Bim-mediated deletion of antigen-specific CD8+ T cells in patients unable to control HBV infection

    A. Ross Lopes;Paul Kellam;Abhishek Das;Claire Dunn

  • Distinct Metabolic Requirements of Exhausted and Functional Virus-Specific CD8 T Cells in the Same Host

    Anna Schurich;Laura J. Pallett;Danyal Jajbhay;Jessica Wijngaarden

  • Pandemic peak SARS-CoV-2 infection and seroconversion rates in London frontline health-care workers.

    Catherine F Houlihan;Nina Vora;Thomas Byrne;Dan Lewer

  • Poly drug use, chemsex drug use, and associations with sexual risk behaviour in HIV-negative men who have sex with men attending sexual health clinics.

    Janey Sewell;Ada Miltz;Fiona C. Lampe;Valentina Cambiano

  • Hepatitis C virus: evidence for sexual transmission.

    R. S. Tedder;R. J. C. Gilson;M. Briggs;C. Loveday

  • Long term probability of detection of HIV-1 drug resistance after starting antiretroviral therapy in routine clinical practice.

    A.N. Phillips;D. Dunn;C. Sabin;A. Pozniak

  • Acute hepatitis C in HIV-infected individuals : recommendations from the European AIDS Treatment Network (NEAT) consensus conference The European AIDS Treatment Network (NEAT) Acute Hepatitis C Infection Consensus Panel

    Matthieu Albert;Jose Benito;Sanjay Bhagani;Christoph Boesecke

  • Increase in diagnosed newly acquired hepatitis C in HIV-positive men who have sex with men across London and Brighton, 2002–2006: is this an outbreak?

    Isabelle Giraudon;Murad Ruf;Helen Maguire;Andre Charlett

  • A placebo-controlled phase I/II study of adefovir dipivoxil in patients with chronic hepatitis B virus infection.

    R. J. C. Gilson;K. B. Chopra;A. M. Newell;I. M. Murray-Lyon

  • Recent advances: Sexually transmitted infections

    Richard J C Gilson;Adrian Mindel

Frequent Co-Authors

Martin Fisher
Martin Fisher University of Sussex
Caroline Sabin
Caroline Sabin University College London
Andrew N. Phillips
Andrew N. Phillips University College London
Clifford Leen
Clifford Leen Western General Hospital
David Dunn
David Dunn University College London
Alison Rodger
Alison Rodger University College London
Chloe Orkin
Chloe Orkin Queen Mary University of London
Brian Gazzard
Brian Gazzard St Bartholomew's Hospital
Margaret Johnson
Margaret Johnson The Royal Free Hospital
Kholoud Porter
Kholoud Porter University College London

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Microbiology in the USA opens doors to various related online degrees and career paths. For those interested in healthcare and patient support, pursuing a career similar to a child life specialist salary can be appealing. This role focuses on helping children and families cope with medical challenges, blending science with compassionate care.

Individuals with a criminal record may worry about educational opportunities, but many online programs welcome diverse backgrounds. Exploring college degrees for felons highlights accessible degree options that can lead to meaningful careers in biology-related fields.

Another growing field is functional medicine, where health is approached holistically. Degrees similar to functional medicine NP programs provide advanced medical knowledge and practical skills for those interested in patient-centered healthcare with a scientific foundation.

For those interested in the administrative side of healthcare, becoming a certified professional coder is a promising path. The CPC salary and career opportunities reflect strong demand for professionals skilled in medical coding and billing, which supports healthcare systems worldwide.

Best Scientists Citing Richard Gilson

Trending Scientists